How has been the historical performance of Ipca Labs?

Answer:The historical performance of Ipca Labs shows a consistent growth trajectory in net sales and profits over the years, with a notable increase in the most recent fiscal year ending March 2025.

Breakdown:
Ipca Labs has demonstrated significant growth in net sales, rising from 4,648.71 crore in March 2020 to 8,939.59 crore in March 2025. This upward trend is reflected in total operating income, which also increased correspondingly. The company's total expenditure has risen from 3,081.30 crore in March 2019 to 7,213.45 crore in March 2025, indicating higher operational costs, particularly in raw materials and employee costs. Operating profit (PBDIT) has shown fluctuations, peaking at 1,818.94 crore in March 2025, while profit before tax reached 1,131.14 crore in the same period. However, profit after tax has varied, with a notable decline from 1,148.84 crore in March 2021 to 787.53 crore in March 2025. The company's total assets have increased significantly from 5,257.82 crore in March 2020 to 11,743.63 crore in March 2025, alongside a rise in total liabilities from 5,257.82 crore to 11,743.63 crore. Cash flow from operating activities has improved, reaching 1,321.00 crore in March 2025, while net cash inflow turned positive at 168.00 crore, contrasting with a negative outflow of 823.00 crore in March 2024. Overall, Ipca Labs has shown resilience and growth in its financial performance, despite some fluctuations in profit margins.